Literature DB >> 28163339

Synthesis and antiviral evaluation of 2',2',3',3'-tetrafluoro nucleoside analogs.

Ozkan Sari1, Leda Bassit1, Christina Gavegnano1, Tamara R McBrayer2, Louise McCormick1, Bryan Cox1, Steven J Coats2, Franck Amblard1, Raymond F Schinazi1.   

Abstract

Herein, we report the synthesis of novel 2',2',3',3'-tetrafluorinated nucleoside analogs along with their phosphoramidate prodrugs. A tetrafluoro ribose moiety was coupled with different Boc/benzoyl-protected nucleobases under Mitsunobu conditions. After deprotection, tetrafluorinated nucleosides 13b, 14b, 20b-22b were reacted with phenyl-(isopropoxy-L-alaninyl)-phosphorochloridate to afford corresponding monophosphate prodrugs 24b-28b. All synthesized compounds were evaluated against several DNA and RNA viruses including HIV, HBV, HCV, Ebola and Zika viruses.

Entities:  

Keywords:  Antiviral; Fluorine; Mitsunobu; Nucleoside; Prodrug

Year:  2017        PMID: 28163339      PMCID: PMC5289701          DOI: 10.1016/j.tetlet.2017.01.006

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  18 in total

1.  Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture.

Authors:  Lieven J Stuyver; Tony Whitaker; Tamara R McBrayer; Brenda I Hernandez-Santiago; Stefania Lostia; Phillip M Tharnish; Mangala Ramesh; Chung K Chu; Robert Jordan; Junxing Shi; Suguna Rachakonda; Kyoichi A Watanabe; Michael J Otto; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 2.  Synthesis of nucleoside phosphate and phosphonate prodrugs.

Authors:  Ugo Pradere; Ethel C Garnier-Amblard; Steven J Coats; Franck Amblard; Raymond F Schinazi
Journal:  Chem Rev       Date:  2014-08-21       Impact factor: 60.622

3.  Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1.

Authors:  R F Schinazi; J P Sommadossi; V Saalmann; D L Cannon; M Y Xie; G C Hart; G A Smith; E F Hahn
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  Nucleosides. 133. Synthesis of 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)cytosines and related pyrimidine nucleosides as potential antiviral agents.

Authors:  M E Perlman; K A Watanabe; R F Schinazi; J J Fox
Journal:  J Med Chem       Date:  1985-06       Impact factor: 7.446

5.  Nucleosides. 136. Synthesis and antiviral effects of several 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-alkyluracils. Some structure-activity relationships.

Authors:  T L Su; K A Watanabe; R F Schinazi; J J Fox
Journal:  J Med Chem       Date:  1986-01       Impact factor: 7.446

6.  Synthesis of tert-butoxycarbonyl (Boc)-protected purines.

Authors:  S Dey; P Garner
Journal:  J Org Chem       Date:  2000-11-03       Impact factor: 4.354

7.  Nucleosides. 129. Synthesis of antiviral nucleosides: 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracils.

Authors:  K A Watanabe; T L Su; U Reichman; N Greenberg; C Lopez; J J Fox
Journal:  J Med Chem       Date:  1984-01       Impact factor: 7.446

8.  Fluorinated Nucleosides: Synthesis and Biological Implication.

Authors:  Peng Liu; Ashoke Sharon; Chung K Chu
Journal:  J Fluor Chem       Date:  2008-09       Impact factor: 2.050

9.  Enantioselective synthesis of tetrafluorinated ribose and fructose.

Authors:  Bruno Linclau; A James Boydell; Roxana S Timofte; Kylie J Brown; Victoria Vinader; Alexander C Weymouth-Wilson
Journal:  Org Biomol Chem       Date:  2009-01-12       Impact factor: 3.876

10.  Improvement of DNA and RNA Sugar Pucker Profiles from Semiempirical Quantum Methods.

Authors:  Ming Huang; Timothy J Giese; Tai-Sung Lee; Darrin M York
Journal:  J Chem Theory Comput       Date:  2014-03-03       Impact factor: 6.006

View more
  3 in total

1.  Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.

Authors:  Keivan Zandi; Leda Bassit; Franck Amblard; Bryan D Cox; Pouya Hassandarvish; Ehsan Moghaddam; Andrew Yueh; Gisele Olinto Libanio Rodrigues; Ingredy Passos; Vivian V Costa; Sazaly AbuBakar; Longhu Zhou; James Kohler; Mauro M Teixeira; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

2.  Carbohydrate Ligands for COVID-19 Spike Proteins.

Authors:  Yung-Kuo Lee; Wen-Chiu Chang; Ekambaranellore Prakash; Yu-Ju Peng; Zhi-Jay Tu; Chun-Hung Lin; Pang-Hung Hsu; Chuan-Fa Chang
Journal:  Viruses       Date:  2022-02-06       Impact factor: 5.048

3.  Moving Fast Toward Hepatitis B Virus Elimination.

Authors:  Leda Bassit; Suzane Kioko Ono; Raymond F Schinazi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.